|
Delayed
Nasdaq
23:13:20 12/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 44.34 USD | -0.49% |
|
-1.21% | +34.55% |
Main features
| US33738R8372 | Fees | 0.6% | Dividend Policy | Distribution | |
|---|---|---|---|---|---|
| Currency | USD | AuM (SAR) | 4.1B | Replication Method | Direct (Physical) |
| Number of securities | 50 | AuM evolution | - | Date of creation | 20/09/2016 |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| FTXH | Delayed | |
CBOE
| FTXH | Real-time |
eff7603669cd5bdca3.MfUuCUAyynSWKmVESnwWh4NEhDxVz9R8osgecuykd4c.QrJ4XwhqjQLaRgIzEkRJ2MYpwUowjOETzKBHX6KQPOlepWdrNlikOv1sNA
| Name |
Indicative Price |
Change |
Weight | |
|---|---|---|---|---|
 | 147.62USD | +0.30% | 8.3% | |
| 284.53USD | +1.47% | 8.24% | |
| 62.70USD | -0.33% | 7.57% | |
| 29.00USD | -1.51% | 6.49% | |
| 295.56USD | +0.20% | 6.31% | |
| 277.86USD | +0.15% | 4.41% | |
| 251.83USD | -0.62% | 4.07% | |
| 1,435.62USD | -0.12% | 4.06% | |
| 952.40USD | -0.73% | 3.88% | |
| 169.19USD | -0.32% | 3.87% | |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
In partnership with
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | United States |
| Theme and Sector | Pharmaceuticals |
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/11/26 | $44.34 | -0.49% | 165,521 |
| 11/11/26 | $44.56 | +0.43% | 120,457 |
| 10/11/26 | $44.37 | -0.00% | 111,205 |
| 09/11/26 | $44.37 | +2.17% | 74,899 |
| 06/11/26 | $43.43 | +0.69% | 111,943 |
- Stock Market
- ETF
- FTXH ETF
Select your edition
All financial news and data tailored to specific country editions
